Willem, L, Xiao, L, Antillon, M, Bilcke, J, Jit, M and Beutels, P. 2020. Multi-Country Model Application for RSV Cost-Effectiveness Policy (McMarcel). [Online]. Zenodo. Available from: http://doi.org/10.5281/zenodo.3663447
Willem, L, Xiao, L, Antillon, M, Bilcke, J, Jit, M and Beutels, P. Multi-Country Model Application for RSV Cost-Effectiveness Policy (McMarcel) [Internet]. Zenodo; 2020. Available from: http://doi.org/10.5281/zenodo.3663447
Willem, L, Xiao, L, Antillon, M, Bilcke, J, Jit, M and Beutels, P (2020). Multi-Country Model Application for RSV Cost-Effectiveness Policy (McMarcel). [Data Collection]. Zenodo. http://doi.org/10.5281/zenodo.3663447
Description
The objective of McMarcel is to evaluate the impact and cost-effectiveness of potential maternal and neonatal RSV immunisation strategies in 72 Gavi countries. The acronym stands for Multi-Country Model Application for RSV Cost-Effectiveness poLicy (McMarcel). If you use (parts of) this modelling project, please cite: Li, Willem, Antillon, Bilcke, Jit, Beutels. Health and economic burden of Respiratory Syncytial Virus (RSV) disease and the cost-effectiveness of potential interventions against RSV among children under 5 years in 72 Gavi-eligible countries. BMC Medicine. (2020).
Data capture method | Other |
---|---|
Date (Date published in a 3rd party system) | 12 February 2020 |
Language(s) of written materials | English |
Data Creators | Willem, L, Xiao, L, Antillon, M, Bilcke, J, Jit, M and Beutels, P |
---|---|
LSHTM Faculty/Department | Faculty of Epidemiology and Population Health > Dept of Infectious Disease Epidemiology |
Participating Institutions | London School of Hygiene & Tropical Medicine, London, United Kingdom |
Date Deposited | 18 Feb 2020 14:07 |
---|---|
Last Modified | 16 Sep 2021 09:15 |
Publisher | Zenodo |